Request for Comments and Announcement of Workshop on Pet Medications Issues, Project No. P121201 #560891-00301

Submission Number:
560891-00301
Commenter:
Shannon Smith
Organization:
Duke University
State:
North Carolina
Initiative Name:
Request for Comments and Announcement of Workshop on Pet Medications Issues, Project No. P121201

My personal pet, a 5 year-old Akita, recently had to have surgery for a perforated gastric ulcer with concomitant septic peritonitis (severe)from meloxicam usage (the human formulation, not Metacam). I didn't know that in some animals, there is something different about the human formulation that causes gastric ulceration at therapeutic doses in dogs. And, my dog is so stoic that I had to convince the surgeon that something was amiss. If I didn't know this, and I am a doctor of veterinary medicine, wouldn't it follow that a client would be even less informed about potential side effects The human pharmacies will not be giving out animal-specific drug labels/information sheets. The owners will be refilling the medications without having bloodwork done to see what effects the drug is having on their pets' internal organs. (It's so easy to change the number of times a medication can be refilled on a prescription). And, unless we call these medications in, a DEA license number on a prescription means more opportunities for clients to call in medications for themselves or change the prescription. This idea seems wrought with potentially devastating effects to not only our profession, but to the animals we serve.